QuantaMatrix (XKRX:317690) Debt-to-Revenue : 2.93 (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is QuantaMatrix Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

QuantaMatrix's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩6,980 Mil. QuantaMatrix's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩588 Mil. QuantaMatrix's annualized Revenue for the quarter that ended in Sep. 2024 was ₩2,587 Mil. QuantaMatrix's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 2.93.

QuantaMatrix Debt-to-Revenue Historical Data

The historical data trend for QuantaMatrix's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QuantaMatrix Debt-to-Revenue Chart

QuantaMatrix Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

2.36

1.15

3.79

1.25

0.31

QuantaMatrix Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Revenue	Get a 7-Day Free Trial															0.55	0.14	2.29	7.80	2.93

Competitive Comparison of QuantaMatrix's Debt-to-Revenue

For the Medical Devices subindustry, QuantaMatrix's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QuantaMatrix's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QuantaMatrix's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where QuantaMatrix's Debt-to-Revenue falls into.

QuantaMatrix Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

QuantaMatrix's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(438.075	+	522.511)	/	3117.942
	=	0.31

QuantaMatrix's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(6979.749	+	588.166)	/	2586.956
	=	2.93

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2024) Revenue data.

QuantaMatrix Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of QuantaMatrix's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

QuantaMatrix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QuantaMatrix Inc (XKRX:317690) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

131, Gasan digital 1-ro, Geumcheon-gu, 16th floor, Bidong (Gasan-dong, BYC High City), Seoul, KOR, 08506

Website

https://www.quantamatrix.com

QuantaMatrix Inc is engaged in research and development, production, and sales of in vitro diagnostic (IVD) medical devices that utilize substances collected from the human body, such as blood, feces, body fluids, and saliva, for the purpose of disease prevention and diagnosis, prognosis prediction, and assessment of health status and treatment effectiveness, targeting domestic and foreign general hospitals and testing contract institutions.

QuantaMatrix Headlines

No Headlines